ESR1 and breast carcinoma: For instance, whether a tumor is positive for the oestrogen receptor (ER), progesterone receptor (PR), or the human epidermal growth factor 2 receptor (HER2, also known as the ErbB2 receptor or neu receptor) is tantamount for defining the subtype of breast cancer and assigning therapeutic intervention.